Prognostic value of nuclear matrix protein expression in localized prostate cancer

Francesco Ricci, Alessandra Rubagotti, Linda Zinoli, Rosa Mangerini, Pier Vitale Nuzzo, Giorgio Carmignani, Alchiede Simonato, Paola Barboro, Cecilia Balbi, Francesco Boccardo

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Purpose: The aim of the study was to correlate nuclear matrix (NM) protein expression profiles with the risk of PSA progression or death in early prostate cancer (PCa). Methods: High-resolution two-dimensional gel electrophoresis (2D-PAGE) was used to identify tumor-associated NM proteins in the PCa specimens obtained from 94 patients. The association between the expression of each protein and the probability of PSA progression or death was studied through univariate analysis. Unsupervised hierarchical clustering analysis was then used to generate patient clusters showing comparable outcomes by including the proteins that were predictive at univariate analysis. PSA-free and overall survival curves relative to each cluster were constructed by means of the Kaplan-Meier method and curves compared by the log-rank test. Multi-parametric models were constructed according to Cox proportional hazard technique. Results: After a median follow-up of 11.7 years (range, 6.5-16.2), 50 patients progressed and 22 died. Of the eight NM proteins identified through 2D-PAGE, proteins NM-6, NM-7 and NM-8 were confirmed to be individually associated with a higher risk of PSA progression at univariate analysis. Proteins NM-6 and NM-8 were also predictive of survival probability. Hierarchical clustering analysis of these proteins allowed to identify one cluster of tumors co-expressing the three proteins or proteins NM-6 and NM-8, characterized by a very poor outcome, suggesting a specific role for these proteins in PCa progression. The predictive value of this mini-signature in respect to PSA-free survival was confirmed by multivariate analysis. Conclusions: Changes in NM scaffolding are strongly associated with the clinical outcome of patients following radical prostatectomy.

Original languageEnglish
Pages (from-to)1379-1384
Number of pages6
JournalJournal of Cancer Research and Clinical Oncology
Volume138
Issue number8
DOIs
Publication statusPublished - Aug 2012

Fingerprint

Nuclear Matrix-Associated Proteins
Nuclear Matrix
Prostatic Neoplasms
Electrophoresis, Gel, Two-Dimensional
Proteins
Cluster Analysis
Survival
Prostatectomy
Neoplasms
Multivariate Analysis

Keywords

  • Nuclear matrix proteins
  • Prognosis
  • Prostate cancer
  • PSA progression

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Prognostic value of nuclear matrix protein expression in localized prostate cancer. / Ricci, Francesco; Rubagotti, Alessandra; Zinoli, Linda; Mangerini, Rosa; Nuzzo, Pier Vitale; Carmignani, Giorgio; Simonato, Alchiede; Barboro, Paola; Balbi, Cecilia; Boccardo, Francesco.

In: Journal of Cancer Research and Clinical Oncology, Vol. 138, No. 8, 08.2012, p. 1379-1384.

Research output: Contribution to journalArticle

Ricci, F, Rubagotti, A, Zinoli, L, Mangerini, R, Nuzzo, PV, Carmignani, G, Simonato, A, Barboro, P, Balbi, C & Boccardo, F 2012, 'Prognostic value of nuclear matrix protein expression in localized prostate cancer', Journal of Cancer Research and Clinical Oncology, vol. 138, no. 8, pp. 1379-1384. https://doi.org/10.1007/s00432-012-1216-0
Ricci, Francesco ; Rubagotti, Alessandra ; Zinoli, Linda ; Mangerini, Rosa ; Nuzzo, Pier Vitale ; Carmignani, Giorgio ; Simonato, Alchiede ; Barboro, Paola ; Balbi, Cecilia ; Boccardo, Francesco. / Prognostic value of nuclear matrix protein expression in localized prostate cancer. In: Journal of Cancer Research and Clinical Oncology. 2012 ; Vol. 138, No. 8. pp. 1379-1384.
@article{4bbb34aaf75444e0b2ae4fbb6ffad946,
title = "Prognostic value of nuclear matrix protein expression in localized prostate cancer",
abstract = "Purpose: The aim of the study was to correlate nuclear matrix (NM) protein expression profiles with the risk of PSA progression or death in early prostate cancer (PCa). Methods: High-resolution two-dimensional gel electrophoresis (2D-PAGE) was used to identify tumor-associated NM proteins in the PCa specimens obtained from 94 patients. The association between the expression of each protein and the probability of PSA progression or death was studied through univariate analysis. Unsupervised hierarchical clustering analysis was then used to generate patient clusters showing comparable outcomes by including the proteins that were predictive at univariate analysis. PSA-free and overall survival curves relative to each cluster were constructed by means of the Kaplan-Meier method and curves compared by the log-rank test. Multi-parametric models were constructed according to Cox proportional hazard technique. Results: After a median follow-up of 11.7 years (range, 6.5-16.2), 50 patients progressed and 22 died. Of the eight NM proteins identified through 2D-PAGE, proteins NM-6, NM-7 and NM-8 were confirmed to be individually associated with a higher risk of PSA progression at univariate analysis. Proteins NM-6 and NM-8 were also predictive of survival probability. Hierarchical clustering analysis of these proteins allowed to identify one cluster of tumors co-expressing the three proteins or proteins NM-6 and NM-8, characterized by a very poor outcome, suggesting a specific role for these proteins in PCa progression. The predictive value of this mini-signature in respect to PSA-free survival was confirmed by multivariate analysis. Conclusions: Changes in NM scaffolding are strongly associated with the clinical outcome of patients following radical prostatectomy.",
keywords = "Nuclear matrix proteins, Prognosis, Prostate cancer, PSA progression",
author = "Francesco Ricci and Alessandra Rubagotti and Linda Zinoli and Rosa Mangerini and Nuzzo, {Pier Vitale} and Giorgio Carmignani and Alchiede Simonato and Paola Barboro and Cecilia Balbi and Francesco Boccardo",
year = "2012",
month = "8",
doi = "10.1007/s00432-012-1216-0",
language = "English",
volume = "138",
pages = "1379--1384",
journal = "Journal of Cancer Research and Clinical Oncology",
issn = "0171-5216",
publisher = "Springer Verlag",
number = "8",

}

TY - JOUR

T1 - Prognostic value of nuclear matrix protein expression in localized prostate cancer

AU - Ricci, Francesco

AU - Rubagotti, Alessandra

AU - Zinoli, Linda

AU - Mangerini, Rosa

AU - Nuzzo, Pier Vitale

AU - Carmignani, Giorgio

AU - Simonato, Alchiede

AU - Barboro, Paola

AU - Balbi, Cecilia

AU - Boccardo, Francesco

PY - 2012/8

Y1 - 2012/8

N2 - Purpose: The aim of the study was to correlate nuclear matrix (NM) protein expression profiles with the risk of PSA progression or death in early prostate cancer (PCa). Methods: High-resolution two-dimensional gel electrophoresis (2D-PAGE) was used to identify tumor-associated NM proteins in the PCa specimens obtained from 94 patients. The association between the expression of each protein and the probability of PSA progression or death was studied through univariate analysis. Unsupervised hierarchical clustering analysis was then used to generate patient clusters showing comparable outcomes by including the proteins that were predictive at univariate analysis. PSA-free and overall survival curves relative to each cluster were constructed by means of the Kaplan-Meier method and curves compared by the log-rank test. Multi-parametric models were constructed according to Cox proportional hazard technique. Results: After a median follow-up of 11.7 years (range, 6.5-16.2), 50 patients progressed and 22 died. Of the eight NM proteins identified through 2D-PAGE, proteins NM-6, NM-7 and NM-8 were confirmed to be individually associated with a higher risk of PSA progression at univariate analysis. Proteins NM-6 and NM-8 were also predictive of survival probability. Hierarchical clustering analysis of these proteins allowed to identify one cluster of tumors co-expressing the three proteins or proteins NM-6 and NM-8, characterized by a very poor outcome, suggesting a specific role for these proteins in PCa progression. The predictive value of this mini-signature in respect to PSA-free survival was confirmed by multivariate analysis. Conclusions: Changes in NM scaffolding are strongly associated with the clinical outcome of patients following radical prostatectomy.

AB - Purpose: The aim of the study was to correlate nuclear matrix (NM) protein expression profiles with the risk of PSA progression or death in early prostate cancer (PCa). Methods: High-resolution two-dimensional gel electrophoresis (2D-PAGE) was used to identify tumor-associated NM proteins in the PCa specimens obtained from 94 patients. The association between the expression of each protein and the probability of PSA progression or death was studied through univariate analysis. Unsupervised hierarchical clustering analysis was then used to generate patient clusters showing comparable outcomes by including the proteins that were predictive at univariate analysis. PSA-free and overall survival curves relative to each cluster were constructed by means of the Kaplan-Meier method and curves compared by the log-rank test. Multi-parametric models were constructed according to Cox proportional hazard technique. Results: After a median follow-up of 11.7 years (range, 6.5-16.2), 50 patients progressed and 22 died. Of the eight NM proteins identified through 2D-PAGE, proteins NM-6, NM-7 and NM-8 were confirmed to be individually associated with a higher risk of PSA progression at univariate analysis. Proteins NM-6 and NM-8 were also predictive of survival probability. Hierarchical clustering analysis of these proteins allowed to identify one cluster of tumors co-expressing the three proteins or proteins NM-6 and NM-8, characterized by a very poor outcome, suggesting a specific role for these proteins in PCa progression. The predictive value of this mini-signature in respect to PSA-free survival was confirmed by multivariate analysis. Conclusions: Changes in NM scaffolding are strongly associated with the clinical outcome of patients following radical prostatectomy.

KW - Nuclear matrix proteins

KW - Prognosis

KW - Prostate cancer

KW - PSA progression

UR - http://www.scopus.com/inward/record.url?scp=84864348572&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864348572&partnerID=8YFLogxK

U2 - 10.1007/s00432-012-1216-0

DO - 10.1007/s00432-012-1216-0

M3 - Article

C2 - 22488172

AN - SCOPUS:84864348572

VL - 138

SP - 1379

EP - 1384

JO - Journal of Cancer Research and Clinical Oncology

JF - Journal of Cancer Research and Clinical Oncology

SN - 0171-5216

IS - 8

ER -